Sanofi
Sanofi is a Healthcare company operating in Drug Manufacturers - General with a $100.01B market cap.
Behavioral analysis
Disclosures
Transcripts
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks SNY's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 9/10 quarters with 70% positive reaction rate
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for SNY.
$ curl https://api.spokenalpha.com/v1/companies/SNYFAQ
Spoken Alpha indexes SNY's earnings call transcripts at https://spokenalpha.com/companies/SNY. Each call links to attributed speakers and parsed analyst Q&A.
Sanofi (SNY) operates in the Healthcare sector (Drug Manufacturers - General industry).
Consistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.62 | $1.61 | +0.7% | -0.8% | +0.9% |
| Q4 FY2026 | $1.74 | $1.59 | +9.2% | +2.9% | +1.3% |
| Q3 FY2026 | $1.91 | $1.81 | +5.6% | +2.1% | +3.0% |
| Q2 FY2026 | $1.65 | $1.66 | -0.5% | +0.8% | -1.9% |
| Q1 FY2025 | $1.78 | $1.76 | +1.4% | +6.4% | +6.9% |
| Q4 FY2025 |
| $1.80 |
| $1.68 |
| +7.1% |
| +4.6% |
| +5.3% |
| Q3 FY2025 | $1.87 | $1.83 | +2.3% | +0.1% | 0.0% |
| Q2 FY2025 | $1.85 | $1.79 | +3.4% | 0.0% | -2.9% |
| Q1 FY2024 | $1.89 | $1.82 | +3.8% | +3.2% | +0.6% |
| Q4 FY2024 | $2.04 | $1.94 | +5.1% | -3.4% | -4.3% |